SARS-Cov-2 and the Case for Empirical  Treatment

SARS-Cov-2 and the Case for Empirical Treatment

Alexandria Watkins

Contact

Richard P. Bartlett

Contact

SARS-Cov-2 and the Case for Empirical Treatment

Article Fingerprint

ReserarchID

6410Y

SARS-Cov-2 and the Case for Empirical Treatment Banner

AI TAKEAWAY

Connecting with the Eternal Ground

References

50 Cites in Article

Reference Format

Daisuke Miyazawa,Gen Kaneko (2020). Inhaled corticosteroids should be effective for COVID-19 treatment.
L Armitage,R Brettell (2020). Not enough evidence for use of vitamin D in prevention or treatment of COVID-19, NICE rapid guidance concludes.
(2020). Protective role of inhaled steroids for COVID-19 infection.
Peter Barnes (2009). How corticosteroids control inflammation: Quintiles Prize Lecture 2005.
O Blennow (2020). Inhalation of ciclesonide for patients with COVID-19: A randomized open treatment study (HALT COVID-19).
Sidney Braman,Brian Carlin,Nicola Hanania,Donald Mahler,Jill Ohar,Victor Pinto-Plata,Tina Shah,David Eubanks,Rajiv Dhand (2018). Results of a Pulmonologist Survey Regarding Knowledge and Practices With Inhalation Devices for COPD.
Budesonide (2004). Wikipedia, the free encyclopedia.
&na; (2019). General Information.
Camilla Christensson,Anders Thorén,Bengt Lindberg (2008). Safety of Inhaled Budesonide.
Giorgio Ciprandi,Maria Angela Tosca,Ignazio Cirillo,Andrea Vizzaccaro (2003). The effect of budesonide on the cytokine pattern in patients with perennial allergic rhinitis.
(2020). Coronavirus search trends.
G Deslée,M Zysman,P-R Burgel,T Perez,L Boyer,J Gonzalez,N Roche (2020). Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges.
Rajiv Dhand,Tricia Cavanaugh,Neil Skolnik (2018). Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease.
A Ek,K Larsson,S Siljerud,L Palmberg (2001). Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages.
J Grant,D Saul,A Lopez,A Hart,M Mcquillan (2014). Risk of serious pneumonia in COPD patients using inhaled corticosteroids.
David Halpin,Dave Singh,Ruth Hadfield (2020). Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective.
Tetsuya Homma,Yosuke Fukuda,Yoshitaka Uchida,Tomoki Uno,Megumi Jinno,Yasunari Kishino,Mayumi Yamamoto,Hiroki Sato,Kaho Akimoto,Keisuke Kaneko,Akiko Fujiwara,Haruna Sato,Kuniaki Hirai,Yoshito Miyata,Hideki Inoue,Shin Ohta,Yoshio Watanabe,Sojiro Kusumoto,Koichi Ando,Shintaro Suzuki,Toshimitsu Yamaoka,Akihiko Tanaka,Tohru Ohmori,Hironori Sagara (2020). Inhibition of Virus-Induced Cytokine Production from Airway Epithelial Cells by the Late Addition of Budesonide.
Miroslav Kubiska,Dalibor Sedláček,Robin Šín (2020). Can serological methods be helpful in the diagnosis of COVID-19 in cases of repeated false negative results of PCR tests?.
Lauren Kucirka,Stephen Lauer,Oliver Laeyendecker,Denali Boon,Justin Lessler (2020). Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure.
Amit Kumar,Yuichi Kubota,Mikhail Chernov,Hidetoshi Kasuya (2020). Potential role of zinc supplementation in prophylaxis and treatment of COVID-19.
S Kumar,S Shao,J Li,Z He,J Hong (2020). Droplet evaporation residue indicating SARS-COV-2 survivability on surfaces.
S Lantero,S Oddera,M Silvestri,R Gonzalez Rodriguez,M Morelli,G Rossi (1999). Budesonide Down-Regulates Eosinophil Locomotion But Has No Effects on ECP Release or on H2O2 Production.
Tania Maes,Ken Bracke,Guy Brusselle (2020). COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?.
Memorial Sloan,Kettering Cancer Center (2020). Managing COVID-19 at home.
Aliae Mohamed-Hussein,Karim Aly,Mohamed-Eltaher A. A. Ibrahim (2020). Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?.
Ralf Minkenberg (2020). Result disclosure on ClinicalTrials. gov — first experiences and challenges.
(2020). Managing COPD patients during the COVID-19 pandemic.
R Newton,L Kuitert,D Slater,I Adcock,P Barnes (1997). Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells.
(2020). No evidence' that inhaled steroids increase risk of COVID-19.
Catherine O'malley (2015). Device Cleaning and Infection Control in Aerosol Therapy.
Romain Pauwels,Søren Pedersen,William Busse,Wan Tan,Yu-Zhi Chen,Stefan Ohlsson,Anders Ullman,Carl Lamm,Paul O'byrne (2003). Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.
Girolamo Pelaia,Luca Gallelli,Bruno D'agostino,Alessandro Vatrella,Giovanni Cuda,Donatella Fratto,Teresa Renda,Umberto Galderisi,Elena Piegari,Nunzio Crimi,Francesco Rossi,Mario Caputi,Francesco Costanzo,Carlo Vancheri,Rosario Maselli,Serafino Marsico (2006). Effects of TGF‐β and glucocorticoids on map kinase phosphorylation, IL‐6/IL‐11 secretion and cell proliferation in primary cultures of human lung fibroblasts.
M Peters,S Sajuthi,P Deford,S Christenson,C Rios,M Montgomery,P Woodruff,D Mauger,S Erzurum,M Johansson,L Denlinger,N Jarjour,M Castro,A Hastie,W Moore,V Ortega,E Bleecker,S Wenzel,E Israel (2020). COVID-19 related genes in sputum cells in asthma: Relationship to demographic features and corticosteroids.
John Arboleda,Silvio Urcuqui-Inchima (2020). Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?.
Beth Russell,Charlotte Moss,Gincy George,Aida Santaolalla,Andrew Cope,Sophie Papa,Mieke Van Hemelrijck (2020). Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence.
Anatoly Skalny,Lothar Rink,Olga Ajsuvakova,Michael Aschner,Viktor Gritsenko,Svetlana Alekseenko,Andrey Svistunov,Demetrios Petrakis,Demetrios Spandidos,Jan Aaseth,Aristidis Tsatsakis,Alexey Tinkov (2020). Zinc and respiratory tract infections: Perspectives for COVID‑19 (Review).
Stephen Stein,Charles Thiel (2017). The History of Therapeutic Aerosols: A Chronological Review.
J Tang,Y Li,I Eames,P Chan,G Ridgway (2006). Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises.
Massimo Triggiani,Francescopaolo Granata,Angelica Petraroli,Stefania Loffredo,Annunziata Frattini,Rosaria Staiano,Guglielmo Monaco,Gianni Marone (2009). Inhibition of Secretory Phospholipase A<sub>2</sub>-Induced Cytokine Production in Human Lung Macrophages by Budesonide.
G Trousdale,K Wise (1991). Beauty and the Beast.
Francesca Valent,Anna Doimo,Giada Mazzilis,Corrado Pipan (2020). RT-PCR tests for SARS-CoV-2 processed at a large Italian Hospital and false-negative results among confirmed COVID-19 cases.
Frank Van De Veerdonk,Mihai Netea,Marcel Van Deuren,Jos Van Der Meer,Quirijn De Mast,Roger Bruggemann,Hans Van Der Hoeven (2020). Kinins and Cytokines in COVID-19: A Comprehensive Pathophysiological Approach.
S Varea (2020). Inhaled corticosteroid treatment of COVID19 patients with pneumonia.
Gwo-Hwa Wan,Ying-Huang Tsai,Yao-Kuang Wu,Kuo-Chien Tsao (2004). A Large-Volume Nebulizer Would Not Be an Infectious Source for Severe Acute Respiratory Syndrome.
(2019). The selection and use of essential medicines, 2025.
S Xi (2009). What people with asthma should know about COVID-19.
X Xu,Y Ong,D Wang (2020). Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinicalguidelines.
Zhikang Ye,Ying Wang,Luis Colunga-Lozano,Manya Prasad,Wimonchat Tangamornsuksan,Bram Rochwerg,Liang Yao,Shahrzad Motaghi,Rachel Couban,Maryam Ghadimi,Malgorzata Bala,Huda Gomaa,Fang Fang,Yingqi Xiao,Gordon Guyatt (2020). Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
G Zijlstra,N Ten Hacken,R Hoffmann,A Van Oosterhout,I Heijink (2011). Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells.
B Zweiman,M Rothenberg (2003). Beyond our pages -Update on SARS (May 30, 2003).

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Alexandria Watkins. 2020. \u201cSARS-Cov-2 and the Case for Empirical Treatment\u201d. Global Journal of Science Frontier Research - I: Interdisciplinary GJSFR-I Volume 20 (GJSFR Volume 20 Issue I4).

More Citation Formats

Select Citation Style:

Download Citation

GJSFR Volume 20 Issue I4

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/GJSFR

Print ISSN 0975-5896

e-ISSN 2249-4626

Keywords

Not Found

Classification

GJSFR-I Classification FOR Code: 110799

Submission ReceivedJuly 7, 2020
Peer Review Double Blind
Handling Editor
Accepted July 30, 2020
Published August 11, 2020

Version of record

v1.2

Issue date

September 24, 2020

Language

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Views: 2409

Total Downloads: 1111

2026 Trends

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]